2-85326798-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006464.4(TGOLN2):c.934G>A(p.Val312Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGOLN2 | NM_006464.4 | c.934G>A | p.Val312Ile | missense_variant | 2/4 | ENST00000377386.8 | NP_006455.2 | |
TGOLN2 | NM_001368095.1 | c.934G>A | p.Val312Ile | missense_variant | 2/4 | NP_001355024.1 | ||
TGOLN2 | NM_001368096.1 | c.934G>A | p.Val312Ile | missense_variant | 2/4 | NP_001355025.1 | ||
TGOLN2 | NM_001206844.2 | c.760G>A | p.Val254Ile | missense_variant | 3/5 | NP_001193773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGOLN2 | ENST00000377386.8 | c.934G>A | p.Val312Ile | missense_variant | 2/4 | 1 | NM_006464.4 | ENSP00000366603 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249240Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135224
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461712Hom.: 0 Cov.: 84 AF XY: 0.0000193 AC XY: 14AN XY: 727138
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2022 | The c.934G>A (p.V312I) alteration is located in exon 2 (coding exon 2) of the TGOLN2 gene. This alteration results from a G to A substitution at nucleotide position 934, causing the valine (V) at amino acid position 312 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at